Asthma, biologics | 合法藥品大搜索

由ATAkenroye著作·2020·被引用17次—...ofCOVID-19maydiffer.Omalizumab(ananti–immunoglobulinE[IgE]antibody​),mepolizumabandreslizumab(whichblockinterleukin[IL]5) ...

As coronavirus disease 2019 (COVID-19) continues to spread across the world, there are concerns that patients with asthma will be at higher risk for the disease or poorer outcomes. There is also concern about whether asthma treatments themselves could worsen the risk of disease or severity.

Current evidence indicates that asthma is not in the top 10 comorbidities associated with COVID-19 fatalities, with obesity, diabetes, and chronic heart disease more commonly reported.1 This finding is consistent with trends during the 2003 severe acute respiratory syndrome coronavirus (SARS-CoV) epidemic, caused by a virus with close sequence homology to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), during which diabetes and heart disease and not asthma were the leading comorbidities.2 However, comorbidities found with COVID-19 fatalities may reflect confoundin...